Accretive describes a transaction or event that increases earnings per share for the acquiring company. In mergers and acquisitions, a deal is accretive when the target adds more to the combined company's earnings than the cost of the acquisition dilutes them. The opposite of accretive is dilutive, where the deal reduces earnings per share after closing.
When one company acquires another, the combined entity's earnings per share either go up or down. The direction depends on how the target's earnings compare to the price paid and how the deal is financed. A deal is accretive when the target's earnings per share contribution exceeds the cost of financing the acquisition on a per-share basis.
A simple rule of thumb: if the acquiring company's price-to-earnings ratio is higher than the target's price-to-earnings ratio, the deal is typically accretive. You are paying a lower multiple for the target's earnings than the market assigns to your own, which increases your combined earnings per share after closing.
The way you pay for an acquisition directly affects whether it is accretive. A cash deal financed with a company's existing reserves adds the target's earnings without increasing the share count. A debt-financed deal adds interest expense but does not dilute equity holders. Either structure is more likely to produce accretion than a deal financed by issuing new shares.
When a company issues new shares to pay for an acquisition, the share count rises. That dilutes earnings per share because the same combined earnings are now divided across more shares. The target's earnings contribution has to be large enough to offset that dilution for the deal to be accretive.
This is where a lot of investors get confused. A deal can be accretive on paper and still destroy long-term shareholder value. Accretion is a short-term earnings-per-share calculation. It does not account for integration challenges, cultural mismatches, competitive disruption, or the eventual erosion of whatever synergies justified the premium paid.
Think of accretion as the first score of a game, not the final result. Winning early matters, but winning by the end is what counts.
Accretive acquisitions typically succeed when the acquirer can identify real synergies in the acquired company. These synergies come in two forms: revenue synergies, where cross-selling or expanded distribution increases combined sales, and cost synergies, where redundant operations, facilities, or headcount are eliminated after closing.
Cost synergies are more predictable and more commonly achieved. Revenue synergies take longer to realize and are harder to guarantee. Acquisition analyses that depend heavily on revenue synergy projections deserve extra scrutiny.
The word "accretive" appears in a second context in finance: bond accounting. When you purchase a bond at a discount to its face value, the difference between your purchase price and the par value accretes over time as the bond approaches maturity. A bond bought at $950 with a $1,000 par value will accrete $50 in value between purchase and maturity. This accretion is recorded as interest income and increases the bond's carrying value on your balance sheet each period.
In this context, accretive simply means the asset is growing in value through the passage of time, which is distinct from the earnings-per-share meaning used in mergers and acquisitions analysis.
An accretion analysis, also called an accretion/dilution analysis, forecasts the impact of a proposed acquisition on the buyer's earnings per share. Analysts project the combined company's earnings, account for the financing structure, model the expected synergies, and calculate whether earnings per share will be higher or lower than the acquirer's standalone earnings per share in the first year after closing.
Most deal teams also model the accretion over a three-to-five-year horizon, since some deals are dilutive in year one but become accretive once synergies are realized. When a chief executive officer claims a deal is "financially compelling," accretion analysis is usually one of the primary pieces of evidence they are pointing to.